Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 12:14:1167741.
doi: 10.3389/fimmu.2023.1167741. eCollection 2023.

State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs

Affiliations
Review

State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs

Flavio Vincenti et al. Front Immunol. .

Abstract

Nephrotic syndrome (NS) is a clinical entity characterized by proteinuria, hypoalbuminemia, and peripheral edema. NS affects about 2-7 per 100,000 children aged below 18 years old yearly and is classified, based on the response to drugs, into steroid sensitive (SSNS), steroid dependent, (SDNS), multidrug dependent (MDNS), and multidrug resistant (MRNS). Forms of NS that are more difficult to treat are associated with a worse outcome with respect to renal function. In particular, MRNS commonly progresses to end stage renal failure requiring renal transplantation, with recurrence of the original disease in half of the cases. Histological presentations of NS may vary from minimal glomerular lesions (MCD) to focal segmental glomerulosclerosis (FSGS) and, of relevance, the histological patterns do not correlate with the response to treatments. Moreover, around half of MRNS cases are secondary to causative pathogenic variants in genes involved in maintaining the glomerular structure. The pathogenesis of NS is still poorly understood and therapeutic approaches are mostly based on clinical experience. Understanding of pathogenetic mechanisms of NS is one of the 'unmet needs' in nephrology and represents a significant challenge for the scientific community. The scope of the present review includes exploring relevant findings, identifying unmet needs, and reviewing therapeutic developments that characterize NS in the last decades. The main aim is to provide a basis for new perspectives and mechanistic studies in NS.

Keywords: focal-segmental glomerulosclerosis; minimal change disease; monoclonal antibodies; nephrotic syndrome; post-transplant recurrence; proteinuria; rituximab.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Classification of NS occurring in childhood based on the response to treatments..
Figure 2
Figure 2
Primary and secondary childhood NS. Inherited forms of NS, caused by pathological variants in genes transcribing for the main protein of glomerular tuft, represent a unique group of NS for which a clear mechanism has been defined. NS associated with either virus infections or drugs are reported as secondary NS on the basis of both the temporal association and reversibility of proteinuria. All other mechanisms are supposed and require further confirmatory results..

References

    1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet (2003) 362(9384):629–39. doi: 10.1016/S0140-6736(03)14184-0 - DOI - PubMed
    1. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, et al. . Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. (2015) 10(4):592–600. doi: 10.2215/CJN.06260614 - DOI - PMC - PubMed
    1. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. (2003) 23(2):117–34. doi: 10.1053/snep.2003.50012 - DOI - PubMed
    1. Maas RJ, Deegens JK, Smeets B, Moeller MJ, Wetzels JF. Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol. (2016) 12(12):768–76. doi: 10.1038/nrneph.2016.147 - DOI - PubMed
    1. Saleem MA. Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol. (2019) 15(12):750–65. doi: 10.1038/s41581-019-0217-5 - DOI - PubMed

Publication types